Susceptibility to antibiotics and drug metabolism in patients with H. pylori infection refractory to the initial treatment--therapeutic strategy based on susceptibility to CAM and CYP2C19 polymorphism

Nippon rinsho. Japanese journal of clinical medicine

Volumn 63 Suppl 11, Issue , 2005, Pages 426-433

  Furuta, Takahisa ^a   Sugimoto, Mitsushige ^a   Nakamura, Akiko ^a   Shirai, Naohito ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; CYP2C19 PROTEIN, HUMAN; ENZYME INHIBITOR; MIXED FUNCTION OXIDASE; PROTON PUMP; UNSPECIFIC MONOOXYGENASE;

ANTIBIOTIC RESISTANCE; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; METABOLISM; PHARMACOGENETICS; REVIEW; TREATMENT OUTCOME;

AMOXICILLIN; ARYL HYDROCARBON HYDROXYLASES; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIXED FUNCTION OXYGENASES; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PROTON PUMPS; TREATMENT OUTCOME;

EID: 33644836269     PISSN: 00471852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)